Gilead Sciences against Novartis AG — live side-by-side technical comparison.
Prices as of 2026-11-10T21:00:01+00:00 UTC · updates daily
GILD leads 4 of the 6 windows we measure — over 1 month GILD is +13.0% and NVS +13.6%; over year to date GILD is +39.2% and NVS +18.4%. The GILD/NVS price ratio stands at 1.0466, above its 50-day average of 1.0329, and above the 200-day average of 0.9281. A ratio above its own average means GILD is gaining on NVS; on this reading the recent edge belongs to GILD.
Compare GILD and NVS: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| GILD | NVS | |
|---|---|---|
| Price | $170.87 | $163.26 |
| 1 day | +0.9%lead | -0.3% |
| 5 days | +2.0% | +2.5%lead |
| 1 month | +13.0% | +13.6%lead |
| 6 months | +30.1%lead | +11.8% |
| Year to date | +39.2%lead | +18.4% |
| 1 year | +44.6%lead | +28.3% |
| 2 years | +76.9% | — |
| 52-week position | 90% of range | 85% of range |
| 52-week range | $116.88–$176.58 | $123.24–$170.46 |
| vs 50-day average | above $154.00 | above $149.25 |
| vs 200-day average | above $141.29 | above $152.41 |
| RSI (14) | 64 | 65 |
| Market cap | $211.9B | — |
| Analyst target | $174.77 (+2.3%) | — |
| Analysts | 26 | — |
| Consensus | Buy | — |
| Next earnings | Oct 29, 2026 | Oct 27, 2026 |
GILD trades at $170.87, above its 50-day average of $154.00, and above the 200-day at $141.29. It sits at 90% of its 52-week range ($116.88–$176.58); 14-day RSI is 64, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $174.48 (2.1% away) and the first support below is $154.00 (9.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
NVS trades at $163.26, above its 50-day average of $149.25, and above the 200-day at $152.41. It sits at 85% of its 52-week range ($123.24–$170.46); 14-day RSI is 65, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $168.62 (3.3% away) and the first support below is $160.57 (1.6% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
GILD is the more volatile of the two — an average session moves it 3.2% against 2.3% for NVS, so an identical position size carries roughly 1.4× the daily risk.
The comparison turns on those levels: GILD clearing $174.48 or losing $154.00; NVS clearing $168.62 or losing $160.57. Until one of them gives way, the relative reading above stands.